An electrochemical clamp assay that enables the rapid and sensitive detection of nucleic acids containing single base mutations has now been developed. It has been shown to differentiate between cancer patient samples featuring a specific mutation, and controls from healthy donors or other cancer patients, all directly in unprocessed serum.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kelley, S. O. et al. Nature Nanotech. 9, 969–980 (2014).
Grieshaber, D., MacKenzie, R., Vörös, J. & Reimhult, E. Sensors 8, 1400–1458 (2008).
Sadik, O. A., Aluoch, A. O. & Zhou, A. Biosens. Bioelectron. 24, 2749–2765 (2009).
Aung, K. L. et al. HUGO J. 4, 11–21 (2010).
Bettegowda, C. et al. Sci. Transl. Med. 6, 224ra24 (2014).
Murtaza, M. et al. Nature 497, 108–112 (2013).
Das, J. et al. Nature Chem. 7, 569–575 (2015).
Chiou, C-C., Luo, J-D. & Chen, T-L. Nature Protoc. 1, 2604–2612 (2006).
National Cancer Institute Pancreatic Cancer www.cancer.gov/cancertopics/types/pancreatic (accessed 18 May 2015).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gorodetskaya, I., Gorodetsky, A. Clamping down on cancer detection. Nature Chem 7, 541–542 (2015). https://doi.org/10.1038/nchem.2290
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchem.2290